Cytotoxic and Pathogenic Properties of Klebsiella oxytoca Isolated from Laboratory Animals by Darby, Alison et al.
Cytotoxic and Pathogenic Properties of Klebsiella
oxytoca Isolated from Laboratory Animals
Alison Darby1., Kvin Lertpiriyapong1.¤, Ujjal Sarkar4, Uthpala Seneviratne4, Danny S. Park2,
Eric R. Gamazon3, Chara Batchelder1, Cheryl Cheung1, Ellen M. Buckley1, Nancy S. Taylor1, Zeli Shen1,
Steven R. Tannenbaum4,5, John S. Wishnok4, James G. Fox1,4*
1Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America, 2 Pharmaceutical Sciences and
Pharmacogenomics Graduate Program, University of California, San Francisco, California, United States of America, 3 Section of Genetic Medicine, Department of
Medicine, The University of Chicago, Chicago, Illinois, United States of America, 4Department of Biological Engineering, Massachusetts Institute of Technology,
Cambridge. Massachusetts, United States of America, 5Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of
America
Abstract
Klebsiella oxytoca is an opportunistic pathogen implicated in various clinical diseases in animals and humans. Studies
suggest that in humans K. oxytoca exerts its pathogenicity in part through a cytotoxin. However, cytotoxin production in
animal isolates of K. oxytoca and its pathogenic properties have not been characterized. Furthermore, neither the identity of
the toxin nor a complete repertoire of genes involved in K. oxytoca pathogenesis have been fully elucidated. Here, we
showed that several animal isolates of K. oxytoca, including the clinical isolates, produced secreted products in bacterial
culture supernatant that display cytotoxicity on HEp-2 and HeLa cells, indicating the ability to produce cytotoxin. Cytotoxin
production appears to be regulated by the environment, and soy based product was found to have a strong toxin induction
property. The toxin was identified, by liquid chromatography-mass spectrometry and NMR spectroscopy, as low molecular
weight heat labile benzodiazepine, tilivalline, previously shown to cause cytotoxicity in several cell lines, including mouse
L1210 leukemic cells. Genome sequencing and analyses of a cytotoxin positive K. oxytoca strain isolated from an abscess of a
mouse, identified genes previously shown to promote pathogenesis in other enteric bacterial pathogens including ecotin,
several genes encoding for type IV and type VI secretion systems, and proteins that show sequence similarity to known
bacterial toxins including cholera toxin. To our knowledge, these results demonstrate for the first time, that animal isolates
of K. oxytoca, produces a cytotoxin, and that cytotoxin production is under strict environmental regulation. We also
confirmed tilivalline as the cytotoxin present in animal K. oxytoca strains. These findings, along with the discovery of a
repertoire of genes with virulence potential, provide important insights into the pathogenesis of K. oxytoca. As a novel
diagnostic tool, tilivalline may serve as a biomarker for K oxytoca-induced cytotoxicity in humans and animals through
detection in various samples from food to diseased samples using LC-MS/MS. Induction of K. oxytoca cytotoxin by
consumption of soy may be in part involved in the pathogenesis of gastrointestinal disease.
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Introduction
Klebsiella oxytoca is a non-motile, gram-negative rod-shaped
bacterium belonging to the family Enterobacteriaceae. K. oxytoca is
ubiquitous in the environment [1] and can be cultured from the
skin, mucous membranes, oropharynx and intestines of healthy
humans and animals, as well as a variety of tissues from clinically
affected humans and animals [2].
In humans, K. oxytoca can be cultured from the stool of 8–10%
of healthy adults [3]. Although most K. oxytoca-infected individ-
uals remain asymptomatic, K. oxytoca is considered an opportu-
nistic pathogen and is now recognized as a clinically significant
pathogen associated with nosocomial infections in hospitalized
patients, including children and neonates [3,4,5]. K. oxytoca also is
purported to be an etiological agent of antibiotic-associated
hemorrhagic colitis (AAHC) in adults and adolescents. Stool
cultures of individuals with AAHC contain K. oxytoca, but do not
contain organisms associated with diarrhea, such as Clostridium
difficle, Campylobacter spp., Salmonella spp., Yersinia spp.,
Shigella spp., and E. coli O157 [6]. AAHC patients develop
clinical signs following antibiotic and/or anti-inflammatory
therapy; these typically include bloody diarrhea, severe abdominal
cramping, and segmental hemorrhagic colitis as visualized by
colonoscopy, most commonly in the ascending colon and the
cecum [4,7,8]. Clinical signs are self-limiting and resolve several
days after antibiotics are discontinued. K. oxytoca has been
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cultured from human patients with septicemia, bacteremia, septic
arthritis, soft tissue infections, cholecystitis, urinary tract infections,
and more recently from colicky neonates [1,9,10,11,12,13,14,15].
Intestinal overgrowth of K. oxytoca has also been observed among
children with celiac disease [16].
In animals, K. oxytoca has been isolated from apparently healthy
sentinel rodents being monitored for pathogens in health
surveillance programs and from utero-ovarian infections including
suppurative endometritis, salpingitis, perioophoritis and peritonitis
in aged B6C3F1 mice on a long term carcinogenicity study
[17,18]. K. oxytoca was also cultured from cases of suppurative
otitis media, urogenital tract infections and pneumonia in C3H/
HeJ and NMRI-Foxn1 (nu) mice, LWE.1AR1 rats, and in mole
voles [19]. Additionally, K. oxytoca was recently cultured from
three breeding colonies of NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
(NSG) mice with chronic renal inflammation and ascending
urinary tract infections [20]. An outbreak of K. oxytoca entero-
colitis on a rabbit farm was also reported [21]. In 2006,
Hogenauer et al. developed a model of AAHC by administering
amoxicillin-clavulanate followed by orally infecting rats with a
strain of K. oxytoca cultured from a patient with AAHC. The
Sprague-Dawley rats developed intestinal lesions primarily in the
cecum. K. oxytoca was subsequently cultured from the rats with
enterocolitis, fulfilling Koch’s postulates and establishing the
positive association between AAHC and K. oxytoca infection [7].
The ability of the human strain of K. oxytoca to colonize and cause
disease in rats experimentally [7] also emphasizes the cross-species
infecting capability of K. oxytoca. Although the experimental
infection study suggests that human strains of K. oxytoca can infect
rats, no evidence to date suggests that K. oxytoca strains from rats
or from other animal species can naturally infect humans and vice
versa.
K. oxytoca strains associated with colitis and mucocutaneous
infections in humans can produce a cytotoxin, which may, in part,
explain K. oxytoca pathogenesis [7]. The cytotoxin described in
1989 and 1992 caused cell rounding and cell death when applied
in vitro to various cell lines including HEp-2, HeLa, CHO, and
Vero cells [22,23]. However, cytotoxin production in K. oxytoca
isolated from animals has not been described [18,19,20].
Furthermore, despite the known clinical effects of K. oxytoca in
humans and animals and the discovery of cytotoxin production in
this bacterium, a complete portrait of its pathogenic mechanisms is
lacking. We hypothesized that - similar to K. oxytoca strains in
humans - K. oxytoca isolates of animal origin also produce
cytotoxin and that K. oxytoca contain a repertoire of genes that
promote pathogenicity. To test this hypothesis, we obtained and
characterized antibiotic resistance patterns in K. oxytoca strains
from various animal species and investigated their ability to
produce cytotoxin under various growth conditions using standard
in vitro cytotoxicity assays previously described [22,23]. Further-
more, we sequenced the genome of a cytotoxin-positive, clinical
isolate from diseased tissue of a mouse and performed in silico
analysis to gain insight into its potential pathogenic properties.
Some of the natural exotoxins produced by Streptomyces and
Micrococci species have a common pyrrolo-benzo-diazepine (PBD)
moiety [24,25]. These area typically cytotoxic class of compounds
consisting of mainly three rings [24]. Tilivalline (Figure 1), for
example, is cytotoxic to mouse leukemia L1210 cells [25,26].
However, the molecular mechanisms of cytotoxicity induced by
these compounds are a matter of active investigation. With the
previous results in mind, we suspected that the cytotoxic activity
present in the supernatant of laboratory animal strains of K.
oxytoca might also be tilivalline. We therefore set out to determine
if tilivalline was present in the culture broth of cytotoxic-positive
strains of K. oxytoca, and correspondingly absent in negative
strains under identical growth conditions, and ascertain whether
tilivalline induced cell abnormalities and death in a cytotoxicity
assay.
Materials and Methods
Strains of K. oxytoca
Sixty four isolates of K. oxytoca isolated from various laboratory
animal species were acquired from several sources and used in this
study. Of the 64 isolates, 48 were from mice (obtained from
Charles River Laboratories (CRL), Jackson Laboratory, MIT
Comparative Medicine diagnostic lab, and National Institute of
Environmental Sciences); 4 isolates were from rats (CRL), 8 from
non-human primates (CRL), 3 from pigs (CRL), and 1 from a
guinea pig (CRL). In addition, a non-toxigenic K. oxytoca strain,
ATCC 13182 [27], was obtained from American Type Culture
Collection (ATCC) and used as a control.
Verification of K. oxytoca isolates
The identities of all 64 strains, previously identified by outside
sources as K. oxytoca, were verified by a combination of API 20E
test (bioMerieux, Marcy l’Etoile, France), polygalacturonase (pehX)
gene amplification, and 16S rRNA gene sequencing. K. oxytoca
DNA was used for subsequent molecular analyses with the Roche
High Pure PCR Template Kit according to the manufacturer’s
recommendations (Roche Applied Science, Indianapolis, IN). For
pehX gene amplification, forward primer PEH C (5’ GAT ACG
GAG TAT GCC TTT ACG GTG -3’) and reverse primer PEH
D (5’- TAG CCT TTA TCA AGC GGA TAC TTG -3’)
(Integrated DNA Technologies, San Diego, CA) [28] were used.
PCR amplification was performed using PuReTaq Ready-To-Go
PCR Beads (GE Healthcare, Piscataway, NJ) as previously
described [28]. The PCR products were resolved on 2% agarose
gel by electrophoresis and stained with ethidium bromide before
visualization. Primer 9F (positions 9 to 27 in the forward direction)
and primer 1541 (positions 1525 to 1541 in the reverse direction)
were used to amplify the 16S rRNA genes from K. oxytoca as
previously described [29]. The PCR products were then purified
using the QIAquick PCR purification kit (Qiagen, Valencia, CA)
and sequenced with an ABI Prism cycle sequencing kit (BigDye
Terminator cycle sequencing kit) on an ABI 3500 genetic analyzer
(Applied Biosystems, Foster City, CA). Sequences were compared
directly with the National Center for Biotechnology Information
(NCBI) Genbank nucleotide database by BLAST search.
Figure 1. Tilivalline structure, chemical formula, and mass.
doi:10.1371/journal.pone.0100542.g001
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Antimicrobial Susceptibility
Antimicrobial susceptibility testing was performed using the disk
diffusion method according to the standards set by Clinical and
Laboratory Standards Institute. Briefly, tryptic soy broth (TSB)
(BD, Franklin Lakes, NJ) was inoculated with K. oxytoca from 24-
hour blood agar cultures and incubated at 37uC for 1 hr. The
cultures were spread evenly on Meuller Hinton agar and antibiotic
discs were aseptically placed on the agar surface. The following
antibiotic discs were used: ampicillin 10mg, cephalothin 30mg,
amoxicillin/clavulanic acid 20/10mg, trimethoprim/sulfamethox-
azole 1.25/23.75mg, enrofloxacin 5mg, and gentamicin 10mg
(Remel, Lexington, KS). Samples were incubated aerobically for
18–24 hours at 37uC and the zones of inhibition were measured to
the nearest millimeter. Measurements were categorized as
susceptible, intermediate susceptibility, or resistant based on the
established values for Klebsiella spp. reported by the manufacturer
(BBL, Becton, Dickinson and Company, Sparks, MD).
Bacterial Cultures
To propagate K. oxytoca, frozen stocks of bacteria were seeded
on blood agar (Remel) and grown for 24 hours at 37uC. To
investigate the effects of environmental conditions on cytotoxin
production, a single colony of K. oxytoca from a 24-hour culture
was inoculated into 8 ml of tryptic soy broth (TSB) and then
subjected to one of four conditions of variable oxygen content.
The first condition was a previously established growth condition
used in investigating cytotoxin production in human isolates of K.
oxytoca [22,23]. This involved culturing K. oxytoca in a 37uC
incubator without agitation for 16 hours with 5% CO2. The
second method was similar to the first method except CO2 was not
provided and gentle agitation at 100 rpm was implemented The
third condition was microaerobic condition (10% CO2, 10% H2,
80% N2) in GasPak (BD, Franklin Lakes, NJ) jars, as previously
described [30]; the culture was incubated at 37uC with gentle
agitation at 100 rpm for 16 hours. The fourth method was
cultivation under anaerobic conditions at 37uC for 16 hours with
agitation using AnaeroPack anaero (Mitsubishi Gas Chemical Co.,
Inc., Chiyoda, TKY). To determine the effect of various growth
media on cytotoxin production, a single colony of K.oxytoca was
inoculated into 8 ml of various types of growth media (see Media
Preparation) and incubated for 16 hours at 37uC under
microaerobic condition with gentle agitation. The incubation
duration of 16 hours was chosen based on the report that
cytotoxin production reaches maximum levels at the end of the
exponential growth phase, approximately 16 hours after inocula-
tion into TSB liquid media [27]. At this stage, the liquid cultures
had OD 660 nm measurement range of 1.4–1.6.
Cytotoxicin Assays
HEp-2 (ATCC-CCL-23) and/or HeLa S3 (ATCC-CCL-2.2)
cell lines were used to investigate cytotoxic activity in K.oxytoca as
previously described [22,23]. Initially, both HEp-2 and HeLa cells
were used to determine cytotoxity of all K. oxytoca strains. Only
HEp-2 cells were used in all other subsequent experiments. Cell
lines were maintained as recommended by ATCC with Hyclone
MEM/EBSS + 2.0 mM L-glutamine, + Earle’s balanced salts
(HyClone Laboratories Inc., Logan, Utah) and 10% fetal bovine
serum (Atlas Biologicals, Fort Collins, CO). Approximately
1.06104 cells suspended in 500 ml of cell culture media were
seeded into 24-well cell culture plates and incubated for 1–2 hours
in 37uC with 5% CO2. To investigate cytotoxin production among
different K. oxytoca strains, 100 mL of supernatant obtained from
liquid culture (see Bacterial Cultures) were added to the wells
containing HEp-2 or HeLa cells. To obtain the supernatant, the
bacteria liquid culture was centrifuged at 8,0006g for 5 minutes.
The resulting supernatant was then filtered through 0.2 mm
Acrodisc syringe filters (PALL Corporation, Port Washington, NY)
to exclude bacteria. Supernatants were either used immediately or
stored at 220uC until assayed. After 48 hours of incubation in
37uC incubator aerated with 5% CO2, the percentage of cells
adhering to the bottom of the well of 24-well plates (% confluency)
indicative of live cells was assessed using an Olympus CK2
inverted phase contrast microscope at 4, 10 and 306magnifica-
tion. To facilitate visualization of the cells and to determine the
total area of cells adhered to the well, Diff Quick straining was also
performed. Cytotoxin-positive samples were characterized as ,
50% confluency i.e., greater than 50% cell rounding and
detachment, as compared to negative control samples (TSB media
only or supernatant of a non-toxigenic K.oxytca strain, ATCC
13182) [27]. Negative control samples had a monolayer of cells
with minimal cell rounding or detachment and confluency in the
range of 80% to nearly 100%. The cytotoxicity assay was
performed at least three times in duplicate wells for each K.
oxytoca to confirm cytotoxin production status.
Heat Inactivation and proteases, trypsin, DNase, and
RNase treatment of Cytotoxin
A 24-hour culture of K. oxytoca, 09-7231, was inoculated into
TSB liquid media and grown under microaerobic conditions with
gentle agitation for 16 hours. One milliliter of filtered supernatant
was obtained and subjected to heat treatment by boiling in a test
tube for 20 minutes or treated with protease (1 mg/ml of
supernatant) or trypsin (0.5 units/100 ml) at 37 uC with continuous
shaking (70 rpm) for 2 hours. For protease and trypsin treatments,
the treated supernatant was subjected to centrifugation at 3000 g
for 1 minute to remove protease and trypsin agarose. Protease and
trypsin agarose (Sigma, St Louis, MO) was reconstituted according
to manufacturer’s recommendations. DNase (20 units/ml, Sigma)
and RNase (10 mg/ml, Sigma) treatments of the supernatant were
performed by incubating at room temperature for 2 hours [31].
One hundred ml of treated supernatant was used for the
cytotoxicity assays [32]. As a control, heated TSB broth and
protease-, trypsin-, DNase-, and RNAse-treated TSB broth were
used. All assays were performed in 3 independent experiments.
Media preparation
Three different types of media: soy extract only, casein extract
only, and TSB, were prepared. Media containing soy extract only
consists of peptic digest of soybean meal (Bacto Soytone, BD;
20 g/L of water), dextrose (2.5 g/L), and NaCl (5 g/L). Media
containing only casein extract consists of pancreatic digest of
Casein (Bacto Tryptone; 20 g/L of water), dextrose (2.5 g/L) and
NaCl (5 g/L). TSB contains pancreatic digest of casein (Bacto
Tryptone 17 g/L), Bacto Soytone (3 g/L), dextrose (2.5 g/L), and
NaCl (5 g/L).
Molecular weight determination
Supernatant from the mouse clinical K.oxytoca isolate, 09-7231-
1, grown under microaerobic conditions as described above, was
subjected to filtration using Centricon Ultracel YM 3 kD and
30 kD membranes (Millipore Corporation, Billerica, MA). Frac-
tions obtained were then assessed in the in vitro cytotoxicity assay
to determine biological activity.
Global gene expression analysis by microarray
Human GE 4644K V2 Microarray (Ilumina) was used to
investigate global gene expression changes associated with the K.
Klebsiella oxytoca in Laboratory Animals
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oxytoca toxin on HEp-2 cells. 16106 HEp-2 cells suspended in
1 mL culture medium were added in each well of the 6-well tissue
culture plate. Two hundred microliters of supernatant from the
cytotoxin positive K. oxytoca, 09-7231, which was subjected to 3K
protein separation membrane, was added to each well. As a
control, HEp-2 cells were treated with TSB media subjected to 3K
protein separation membrane. Six hour post treatment, the cells
were collected and RNA extracted using a combination of Trizol
and RNA extraction kit (Qiagen). Samples from 4 independent
toxin treated and control tissue culture wells were used for
microarray analysis. RNA samples were processed by MIT
Biomicro Center (http://openwetware.org/wiki/BioMicroCenter).
The samples were labeled according to Agilent Two-Color
Microarray-based Gene Expression Analysis Protocol (Low Input
Quick Amp Labeling Kit) (http://www.chem.agilent.com/library/
usermanuals/public/G4140-90050_GeneExpression_TwoColor_6.
6.pdf). RNA was hybridized to Human GE 4644 v2 microarray
(Agilent Technologies, Santa Clara, CA). Arrays were washed and
scanned using the G2565 Microarray Scanner (Agilent Technolo-
gies). For visualization, mRNA expression analysis and other
bioinformatics analyses of the microarray data, we utilized Agilent’s
GeneSpring GX software suite. We performed differential expres-
sion analysis using the t-test against the null hypothesis of no change
on each of , 34000 probes. Multiple testing correction for the
differential expression analysis was done using the Benjamini-
Hochberg method. We conducted Gene Ontology functional
annotation enrichment analysis using DAVID as well as pathway
enrichment analysis in GeneSpring GX for the genes that showed
significant differential expression (padjusted,0.05). In these enrich-
ment analyses, padjusted,0.05 (using the Benjamini-Hochberg
procedure) was defined as significant.
Tilivalline detection by LC-MS and LC-MS/MS
HPLC grade chloroform and acetonitrile, formic acid for LC-
MS, and LC-MS/MS were purchased from Sigma Aldrich. The
supernatant from culture broth was extracted with chloroform,
dried, and resuspended in 50 mL 2% acetonitrile containing 0.1%
formic acid. Samples were analyzed with an Agilent 1290 ultra-
high pressure liquid chromatography system (Waldbronn, Ger-
many) interfaced with a 6530 quadrupole time-of-flight (QTOF)
mass spectrometer with a Jetstream electrospray ionization source
and MassHunter workstation (version B.06). The column was an
Agilent C18 (2.1650 mm, 1.8 mm). Mass spectra were acquired in
the positive ion mode from m/z 60 to m/z 1000 at 4 scans per
second. The ion spray voltage was 3,800 V, and the heated
capillary temperature 350uC. Two reference masses (m/z 121.0509
(C5H4N4) and m/z 922.0098 (C18H18O6N3P3F24) were infused
during the runs. The column thermostat and autosampler
temperatures were 50uC and 6uC, respectively. The solvents were
water with 0.1% formic acid and acetonitrile containing 0.1%
formic acid. The gradient was 2% to 90% B over 5 minutes, at
0.5 mL/min.
MS/MS was generated on an Agilent QTOF 6530 mass
spectrometer (Santa Clara, CA) to further confirm the identity of
the metabolites. The column and gradients were the same as those
used for metabolite profiling. The AJS-ESI source was set as MS
scan mode. A targeted list, which included previously determined
exact masses according to results obtained with extracted ion
chromatogram (EIC), was generated for fragmentation.
Isolation of tilivalline
The supernatant from the growth media (1 L) was extracted in
500 mL portions, each with 250 mL of chloroform (3X). The
combined organic phase was dried (anhydrous sodium sulfate),
concentrated under reduced pressure, and the crude product was
semi-purified by automated reverse phase flash chromatography
(Biotage) using a water/methanol gradient. The fractions eluting
at 65% methanol were collected, concentrated under reduced
pressure and re-dissolved in 5% acetonitrile in water. Aliquots
were further purified by preparative HPLC with an Agilent
Technologies model 1100 HPLC system equipped with a
photodiode array UV detector (Wilmington, DE). UV absorbance
was monitored at 254 nm. A semi-preparative Phenomenex Luna
C18 (25 cm69.4 mm, 10 mm) column was eluted with a linear
gradient of 0.1% formic acid in water (A) and 0.1% formic acid in
acetonitrile (B) at a flow rate of 2.5 mL/min. Solvent composition
was initially at 10% for 5 min, changed to 50% over 10 min,
changed from 50% to 70% B over 15 min, and then further to
95% B over 2 min, held for 8 min, followed by returning to 10% B
over 2 min for a total run time of 42 min. The column was
equilibrated for 10 minutes between injections. The fractions
eluting around 21.4 minutes (Figure S5) were collected and
combined for toxicity evaluation and NMR analysis (Figure S4).
Genome sequencing and In Silico Analysis
To further explore the pathogenic mechanisms of K. oxytoca,
the genome of the mouse K. oxytoca strain, 09-7231-1, was fully
sequenced in collaboration with the Broad Institute of Harvard
and MIT (Klebsiella group Sequencing Project (http://www.
broadinstitute.org/)). The full genomic sequence was deposited at
the National Center for Biotechnology Information (NCBI
accession: PRJNA52135). Using a comprehensive set of reference
‘‘heat-labile toxins’’ obtained from NCBI (n= 920), we conducted
homology searches and used the BLOSUM80 scoring matrix [33],
which was created based on local alignments of highly homologous
($ 80%) proteins. We assumed that domains contributing to the
virulence and heat liability should be highly conserved between
bacterial strains since these key functions are essential to their
fitness. We varied the E-value threshold to the maximum value of
10, as it is possible to have a high percentage of homologues in
BLAST results with E-values ranging from 0 to 10. Indeed, a study
by Boekhorst. et al., revealed that, when querying annotated
protein families in the PFAM database [34,35], 65% of BLAST
hits with E-values greater than 1e-03 and less than 10 were known
homologues of the query protein according to PFAM. Addition-
ally, the same study found that 43% of BLAST hits with E-values
greater than 1 and less than 10 were known homologues [35].
Using the thresholding approach to prioritize hits, we aimed to
include all genes that could be potential K. oxytoca cytotoxin
proteins. We performed in-depth analyses of the subset of toxins
that met an E-value cutoff of 1. In this last set of genes, we
included the toxin, PaxA, because one of its transporters, PaxB,
had produced statistically significant results in our first round of
BLAST analyses. We calculated the molecular weights of the
subset of toxins showing homology at the chosen E-value
threshold, using the ‘‘Compute pl/Mw’’ tool on the ExPASy
server [36].
Statistical analysis
We tested whether there was a significant relationship between
the percentages of K. oxytoca strains producing cytotoxin in one
growth condition version another growth condition using a Chi-
squared test with 2 degrees of freedom.
Klebsiella oxytoca in Laboratory Animals
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Results
Animal isolates of K. oxytoca
Sixty four isolates from various animals were confirmed as K.
oxytoca (Table 1). Of the 48 mouse isolates, 14/48 (29%) were
cultured from the respiratory tract, 19/48 (40%) from feces of
asymptomatic mice, 4/48 (8%) isolates from abscesses in the lung,
palpebral conjunctiva, and a tumor, and 11/48 (23%) from
unknown tissues or sites. Of the 4 rat isolates, 1 was isolated from
mammary lesions, while the rest were isolated from unknown
tissue. Three of 8 isolates of the non-human primates were
obtained from feces; tissue origins of the 5 remaining primate
isolates, the pig and guinea pig isolates were unknown (Table 1).
Given that K. oxytoca isolates have varying pathogenic
potentials which could, in part, be attributed to their antibiotic
resistant signatures (Table 2), we determined the antibiotic
resistant characteristics of each of these isolates. Overall, 27/64
(42%) of the isolates were resistant to cephalothin, 5/64 (8%) to
amoxicillin clavulanate, 4/64 (6%) to trimethoprim/sulfamethox-
axole, 4/64 (6%) to enrofloxacin, and 2/64 (3%) to gentamicin.
All 4 isolates that were resistant to trimethoprin/sulfamethoxole,
enrofloxacin, and 2 isolates that were resistant to gentamicin were
exclusively from non-human primates. All K. oxytoca strains were
resistant to ampicillin, a key characteristic of this b-lactamase
organism [27] (Table 2).
Cytotoxin production of K. oxytoca isolates of animals
To determine whether K. oxytoca strains isolated from animals
produced cytotoxin, we performed in vitro cytotoxicity assays
using both HEp-2 and HeLa S3 cells (See Materials and
Methods). All K. oxytoca strains were grown using the previously
reported culturing methods [22,23], which were also described in
Material and Methods. Of the 64 isolates of K. oxytoca
investigated, 18 (28%) isolates were found to induce greater than
50% cell abnormality and death (, 50% confluency), fulfilling our
criteria for classifying the bacteria as cytotoxin positive (Table 3).
As expected, the non-toxigenic strain of K.oxytoca, ATCC 13182,
produced supernatant that did not have any obvious effects on
HEp-2 and HeLa cells (Figure 2). Compared to HeLa cells, HEp-2
cells were more susceptible to cytotoxin produced by K. oxytoca
isolates investigated (data not shown); therefore, HEp-2 cells were
used in the subsequent experiments.
Growth conditions influence cytotoxin production in K.
oxytoca
Previous investigations on cytotoxin production in strains of K.
oxytoca isolated from human patients were performed under static
aerobic conditions i.e., in TSB liquid media incubated in 37uC
incubator without agitation [4,22,23]. Because K. oxytoca can
thrive in various environmental conditions (e.g. on the skin where
O2 tension is high relative to the gastrointestinal tract), we
hypothesized that cytotoxin production of K. oxytoca may be
differentially regulated depending on environmental condi-
tions[37,38,39,40]. Therefore, in addition to the static culturing
conditions commonly used (AR), we subjected all K. oxytoca
isolates to three additional in vitro conditions – aerobic conditions
with gentle agitation without CO2 (AG), microaerobic conditions
with gentle agitation (MG), and anaerobic conditions (AN) (See
Materials and Methods) – and evaluated whether these
various conditions have different effects on cytotoxin production.
Gentle agitation was implemented for aerobic and microaerobic
conditions to ensure maximum exposure of bacteria to O2 in
aerobic conditions as well as CO2, H2, and N2 present in the
microaerobic conditions. While 10/48 (,20%) of mouse isolates
were found to be cytotoxin positive under AR, 20/48 (,42%) and
18/48 (,38%) were cytotoxin positive under AG and MG,
respectively (Table 3). This increase in the number of cytotoxin
positive strains was statistically significant between AR and AG
(p= 0.03), whereas the difference in AR and MG showed a trend
toward significance (p = 0.07). Of the 20 mouse isolates that were
cytotoxin positive under AG, only 7 of these isolates were also
considered as cytotoxin positive under AR (Table 3). The
Table 1. Sources and origin of Klebsiella oxytoca used in this study.
Species N= Source Tissue/Media
G. Pig 1 Diagnostic Lab Unknown
Mouse 19 Diagnostic Lab 1 Feces
Mouse 1 Diagnostic Lab 1 Lung Abscess
Mouse 12 Diagnostic Lab 1 Nasal Culture/Flush
Mouse 1 Diagnostic Lab 1 Palpebral Abscess
Mouse 6 Diagnostic Lab 1 Unknown
Mouse 2 Commercial Vendor Unknown
Mouse 2 Diagnostic Lab 2 Abscess, nu/nu mouse
Mouse 3 Diagnostic Lab 2 Unknown
Mouse 2 Diagnostic Lab 3 Nasal Flush
Rat 1 Diagnostic Lab 1 Mammary Lesion
Rat 3 Diagnostic Lab 1 Unknown
Simian 3 Diagnostic Lab 1 Feces
Simian 5 Diagnostic Lab 1 Unknown
Swine 3 Diagnostic Lab 1 Unknown
Ref. 1 ATCC 13182 Human Pharyngeal tonsil
Total 65
doi:10.1371/journal.pone.0100542.t001
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remaining 3 mouse isolates that were cytotoxin positive under AR
were cytotoxin negative under both AG and MG. All 3 rat isolates,
a guinea pig isolate, and a pig isolate that were all cytotoxin
positive under AR were also cytotoxin positive under both AG and
MG (Table 3). In contrast, a single K. oxytoca strain isolated from
a non-human primate was positive under AR; however, it was
negative on both AG and MG. Another K. oxytoca strain from a
non-human primate was cytotoxin positive under both AG and
MG, but was cytotoxin negative under AR (Table 3).
To investigate the effects of AN on cytotoxin production, 34
selected isolates of K. oxytoca (mice: 25; non-human primates: 4;
guinea pigs: 1; pigs: 1; rats: 3), all of which produced cytotoxin
when incubated under AG and MG, were grown under AN. Only
8/34 (23%) (3 mice; 3 rats; 1 guinea pigs; 1 pig) were positive for
cytotoxin production (data not shown). Together, these results
suggest that AG and MG have a stronger positive effect on
cytotoxin production in K. oxytoca as compared to AR and AN.
Moreover, these results suggest that cytotoxin production among
different strains of K. oxytoca is under complex environmental
regulations.
Intriguingly - although perhaps coincidentally - 13/22 (59%) K.
oxytoca isolates from feces were cytotoxin positive under at least
one of the culturing conditions; virtually the same percentage (9/
14; 64%) from the respiratory tract were cytotoxin positive. Of the
four clinical isolates of K. oxytoca (3 mouse isolates isolated from
either a lung abscess, a palpebral abscess, and a tumor abscess, and
a single isolate isolated from mammary lesions in a rat (Table 1),
only one isolate (mouse isolate, 09-7231-1, from a tumor abscess)
was positive for cytotoxin.
Soy broth induces strong toxin production in K. oxytoca
Toxin production in enteric bacteria, such as Clostridium
difficile, has been shown to be regulated by nutrients [41]. To
investigate this possibility in K. oxytoca, K. oxytoca, 09-7231-1, was
grown in various growth media with varying nutrient compositions
(See Materials and Methods). This mouse isolate was chosen
because it displays the ability to produce cytotoxin consistently and
with the highest degree of cytotoxicity in the cell lines used in the
cytotoxicity assays. In addition to trypticase soy broth (TSB),
which is a standard media used to cultivate K. oxytoca and in
which toxin production has been consistently observed, LB, a
growth media with less nutrients compared to TSB, and Heart
Brain Infusion (HBI) broth, which is richer in nutrients compared
to TSB, were used. Toxin production under the three growth
media was evaluated temporally. Toxin production was found to
be highest in TSB, moderate in HBI, and lowest/nonexistence in
LB media (Figure 3).
HBI contains nutrients mainly from animal products. In
contrast, LB contains nutrient extracted from yeast. On the other
hand, nutrients present in TSB are obtained mainly from soy
product. Based on the observation that K. oxytoca grown in TSB
produce supernatant with the highest toxicity, we hypothesize that
soy product in TSB may contain compounds that contribute to the
high toxin production in K. oxytoca. Therefore, we tested the
cytotoxicity of supernatant obtained from three different media
with well-defined source of nutrients: media contains soy extract
only, media contains animal extract only (casein extract), and
media contains both soy and casein extract (TSB). Media
containing only the soy extract induces a high degree of cell
abnormality and death leading to 1% confluency among HEp-2
cells as early as 18 hours post treatment (Figure 4). As expected,
TSB media also induced cell abnormality and death in HEp-2, but
to a lesser degree (30% confluency at 18 hours post treatment
(data not shown)) compared to media containing only the soy
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Table 3. Cytotoxin of K. oxytoca varies with different growth conditions.
Species of origin Number of strains Supernatant Growth Conditions
Aerobic w/5% CO2 (AR) Aerobic w/agitation (AG) Microaerobic w/agitation (MG)
(No. + (%)) (No. + (%)) (No. + (%))
Mouse 48 10 (20.8) 20 (41.7) 18 (37.5)
Rat 4 3 (75) 3 (75) 3 (75)
Simian 8 3 (37.5) 3 (37.5) 3 (37.5)
Swine 3 1 (33.3) 1 (33.3) 1 (33.3)
G. pig 1 1 (100) 1 (100) 1 (100)
ATCC 13182 1 0 (0) 0 (0) 0 (0)
Total 65 18 (28) 28 (45) 26 (44)
doi:10.1371/journal.pone.0100542.t003
Figure 2. Animal isolates of K. oxytoca produce cytotoxin. HEp-2 cell culture inoculated with K. oxytoca supernatant and media control at 4, 10,
and 306magnifications. A) Media control showing normal morphology of cells stained with Diff-quick after 48 hours of incubation. B) K. oxytoca,
ATCC 13182, isolate negative for cytotoxin production showing normal cell morphology. C) K. oxytoca isolate, 09-7231-1, positive for cytotoxin
production showing abnormal cell morphology, decreased concentration of attached cells, small round cells, and multinucleated cells.
doi:10.1371/journal.pone.0100542.g002
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extract. Like the negative control, media containing only the
casein extract did not cause any significant alteration in monolayer
confluency (,100% confluency). All control media also did not
have an effect on HEp-2 cells (data not shown), lessening the
possibility that nutrients and components in the media are
responsible for inducing HEp-2 cell death. Together, these results
Figure 3. Temporal pattern of cytotoxicity in various conventional bacterial growth media. K. oxytoca, 09-7231-1, was cultured in A) LB;
B) TSB; and C) HBI liquid media. At various time points, the supernatant was collected and used in the cytotoxicity assay using HEp-2 cells. TSB media
has the strongest cytotoxin induction capability compared to LB and HBI media. The degree of cytoxicity is indirectly proportional to the level of
monolayer confluency i.e., the higher % the confluency, the lower the cytotoxity and vice versa.
doi:10.1371/journal.pone.0100542.g003
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suggest that the soy component in TSB promotes cytotoxin
production in K.oxytoca, 09-7231-1.
K. oxytoca cytotoxin is a small heat labile molecule
It was previously demonstrated that human strains of K. oxytoca
produced cytotoxin with an approximate size of 200 Daltons [22].
We investigated the size of cytotoxin produced by the mouse
isolates, 09-7231-1, using protein size exclusion and in vitro
cytotoxicity assays (See Materials and Methods). Both 3 KD
concentrate and filtrate and 30 KD filtrate cause cell monolayer
destruction resulting in ,10% confluency, whereas 30 KD
concentrate did not have obvious effects on the cell monolayer
(,100% confluency) (Figure S1). In addition, protease, trypsin,
DNase, and RNase treatment did not alter the cytotoxic activity of
the toxic molecule present in the supernatant of K. oxytoca (data
not shown); however, heat treatment completely inactivated the
cytotoxic activity of the toxic molecule (Figure S1). There results
suggest that the cytotoxin present in the supernatant of K. oxytoca,
09-7231-2, is likely a small, heat labile compound. Furthermore,
the compound is unlikely to be RNA, DNA, or protein.
Additionally, supernatant placed in room temperature for as long
as 8 weeks exhibited strong cytotoxicity on HEp-2 cells indicating
that the toxin is stable at room temperature (data not shown).
Tilivalline confers cytotoxicity in vitro
Our studies suggested that the toxic compound was a small
endogenous and heat labile molecule. Given previous studies from
human K. oxytoca isolates indicated that tilivalline is the key toxin,
we examined the cytotoxin-positive and cytotoxin-negative strain
cultures for tilivalline. Comparison of LC-MS chromatograms
from control and toxic culture media (Figure S2) revealed a
compound in the toxic media with a protonated molecular ion
([M+ H+]+) at m/z= 334.1561, corresponding to a molecular
weight of 333.1483 Da - within 2 ppm of that calculated for
tilivalline: 333.1477 Da. CID spectra from the [M + H+]+ ion
included fragments characteristic of tilivalline at m/z=316.1454,
219.109, 199.1237, and 136.040 (Figure S3). The proton NMR
spectrum (Figure S4) from a culture isolate, while weak due to the
small amount of material, was also consistent with that reported
for tilivalline [42]. Consistent with previous reports, tilivalline
(1 mg/ml) induced cell abnormalities and death in HEp-2 cells
(Figure 5).
Toxin-induced perturbation using mRNA profiling
To investigate the molecular mechanism of toxin-induced cell
death, we performed differential expression analyses on more than
34000 probes, each representing a gene, using the Human 4644
GE v2 Agilent array. Plotting the log2 (fold change) and –log10
Figure 4. Soy components in TSB induced HEp-2 cell detachment and death. HEp-2 cells treated with A) media containing only casein
extract (Tryptone; control); B) supernatant of K. oxytoca, 09-7231-1, grown in media containing only casein extract; C) media containing only soy
extract (Soytone); D) supernatant of K. oxytoca, 09-7231-1, grown in the media containing only soy extract.
doi:10.1371/journal.pone.0100542.g004
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(corrected p-value) from the differential expression analysis, we
found a large number of toxin-perturbed gene expression traits
(see volcano plot in Figure S6, where each red point indicates a
differentially expressed gene). Table S1 lists the most significantly
perturbed genes (padjusted,0.05) including the direction of effect.
Notably, we found that the genes whose expression levels were
significantly altered by the presence of the toxin were enriched in
the following pathways: androgen receptor, hedgehog, ID
signaling, NOTCH, TGFBR, and TNF alpha/NF-kB. Some of
the most significant Gene Ontology functional annotations (Table
S2 for comprehensive list) include regulation of RNA metabolic
process (padjusted = 1.03610
235), regulation of nitrogen compound
metabolic process (padjusted = 1.46610
230), negative regulation of
apoptosis (padjusted = 1.2610
23), response to DNA damage stimulus
(padjusted = 1.75610
23), and cell cycle (padjusted = 0.003).
Potential virulence genes of K. oxytoca
Although the cytotoxic properties of tilivalline may in part
explain the pathogenesis of the animal isolates K. oxytoca. other
pathogenic mechanisms present in the bacteria may also
contribute to its success as a pathogen. To further explore this
possibility, the genome of a cytotoxin positive mouse isolate of K.
oxytoca, 09-7231-1, was fully sequenced, and its genome was
analyzed to determine if virulence genes identified in other
bacteria were present. Based on current annotation, the entire
genome of K. oxytoca, 09-7231-1, is 6.17Mb in size and has the G+
C content of 54.78%. Nearly 88% (5,673 genes) of the genome is
comprised of coding regions. Additionally, the genome contains 74
tRNAs and 22 rRNAs. Among genes annotated as having known
function, genes that encode type I, type IV, and type VI secretion
systems were detected. Other genes present in this strain include
those involved in nitrate and allantoin metabolism, iron uptake,
resistance to various toxic and antimicrobial compounds, e.g. beta-
lactamase, macrolide, and citrate fermentation. A gene encoding
ecotin, which is involved in host immune modulation, was also
found. Evidence of transposon and phage genetic elements was
also detected. Genes encoding type 1 and type 3 pilli shown to be
involved in biofilm formation as well as a large set of housekeeping
and structural genes were present (Table S3). These housekeeping
and structural genes include those that are involved in the
metabolism of various amino acids, fatty acids, sugars, as well as
transportation of ion, organic and inorganic compounds, DNA
synthesis, cell division and growth, stress responses, and motility.
The genome also contains a gene encoding colicin, which
promotes bacterial fitness by killing competing bacteria through
membrane depolarization [43].
Chromosomally encoded putative toxins
To investigate whether other known bacterial toxin(s) besides
tilivalline may be produced by K.oxytoca, we performed in silico
analyses using the blastp algorithm[44] against the whole genome
assembly of K. oxytoca, 09-7231-1, that we generated. Compre-
hensive analysis of the genome sequence revealed genes with
significant homology to toxin components of Vibrio cholera,
Citrobacter freundii, and Escherichia coli (http://home.uchicago.
edu/,egamazon/koxytoca/index.html). Our first round of
BLAST analyses showed PaxB to have high homology (E-
value = 0) to hypothetical proteins in the K. oxytoca strain. PaxB
plays a role in secreting the RTX toxin, PaxA, in Pasteurella
aerogenes [45]. Although the roles of these largely uncharacterized
K. oxytoca genes have not been fully elucidated, the high homology
between the proteins suggests some type of transportation role that
warrants future functional validation.
Additionally, genes encoding proteins with high similarity to
known heat-labile toxins in other enteric pathogens were identified
(Figure 6). Two of these toxins - the cholera toxin (CT) in V.
cholerae, and the heat-labile toxin (LT) in enterotoxigenic E. coli
strains (ETEC) - are particularly interesting. They both typically
consist of 2 subunits—a catalytic A subunit and an immunogenic B
subunit [46]. BLAST analysis indicated that the K. oxytoca strain
contained a gene with homology to a partial sequence of a known
cholera toxin (CT) A subunit, containing the conserved domain
pfam01375 (Figure 6).
BLAST analysis also revealed genes with homology (E-value,
0.25) to CFXB from C. freundii 48. CFXB encodes a 12-residue
polypeptide with 73.8% sequence identity with the beta subunits of
LT and 72.8% sequence identity with the beta subunit of CT [46].
CFXB, with a molecular weight of 14.2 kDa, contains the
conserved domain pfam01376 for the heat-labile enterotoxin beta
chain.
Figure 5. Tilivalline induced HEp-2 cell detachment and death. A) HEp-2 cells incubated with the control DMSO, which was used to dissolve
tilivalline. The majority of cells adhered to the bottom of the cell culture well after 48 hours of culture; B) HEp-2 cells treated with purified tilivalline
(1 mg/ml) were detached from the cell culture well after 48 hours of incubation.
doi:10.1371/journal.pone.0100542.g005
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Discussion
This study investigated the possibility that animal isolates of K.
oxytoca produce a specific cytotoxin and explored the mechanisms
governing its pathogenicity with in vitro assays as well as genome
sequencing and analysis. To accomplish this, we characterized 64
isolates of K. oxytoca from various animal species. Of these K.
oxytoca strains, 18 (28%) produced supernatant that caused HEp-2
and HeLa cell detachment and death when grown under in vitro
conditions previously used to identify cytotoxin-positive human
strains of K. oxytoca [4,22,23]. This indicates that K. oxytoca of
animals, similar to those isolated from humans, produce cytotoxin
that, in part, may be responsible for promoting K. oxytoca
pathogenesis.
Our results indicate K. oxytoca cytotoxin production is under
strict environmental regulation. Specifically, microaerobic and
aerobic conditions i.e, AG and MG, were more effective in
promoting cytotoxin production among K. oxytoca strains
investigated compared to anaerobic (AN) and static aerobic
conditions (AR). Although AR provides anaerobic condition
Figure 6. The reference proteins encoded by CTA, CFX B, and PAX B are displayed as colored bars. The arrow beneath the bar shows the
region in the reference protein to which the corresponding K. Oxytoca protein aligns from the BLAST analysis.
doi:10.1371/journal.pone.0100542.g006
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initially, it actually resembles an anaerobic condition after
16 hours of culture when oxygen is depleted by the growing
population of bacteria. The resulting anaerobic condition of AR
may explain the lower effect on cytotoxin production similarly
observed in AN as compared to AG and MG. The observation
that AG and MG have greater promoting effects on cytotoxin
production in K. oxytoca compared to AN may, in part, explain
why K. oxytoca has been reported to cause lesions in the mammary
gland, eye, ear, respiratory and urogenital tract, where O2 tensions
are relatively high, and diseases associated with gastrointestinal
tract, which offers K. oxytoca a microaerobic environment for
growth. The aerobic and microaerobic conditions these tissues
provide may favor high level of cytotoxin production and thus
greater cell death. These results are not surprising as environ-
mental regulation of virulence genes and toxin production has also
been observed in other gastrointestinal pathogens, such as Shigella
spp., E. coli, Yersinia enterocolitica and Mycobacterium avium
[37,38,39]. Surprisingly, cytotoxicity of K. oxytoca was also found
to be influenced by nutrients, and soy extract appears to have
promoting effects on the production of toxin. It is increasingly
cited that soy products have a negative effect on gastrointestinal
health in animals and humans. For example, there is an increasing
incidence of food protein-induced enterocolitis and other inflam-
matory bowel disease entities that coincide with increased
consumption of soy products [47,48,49]. It is therefore possible
that soy-induced toxin production in gut microbes, including K.
oxytoca, may in part play a role in the pathogenesis of
inflammatory bowel diseases in susceptible individuals. Further
investigations are needed to investigate this possibility and to
determine how soy products promote cytotoxin production in K.
oxytoca.
Of the 4 clinical K. oxytoca isolates obtained from laboratory
animals, only one isolate was cytotoxin positive. In a related study,
K. oxytoca was isolated from 14 of 200 patients (7%) being
screened for vancomycin-resistant enterococci (VRE), but only one
of the 14 isolates (7.1%) was cytotoxic [12]. In another study, K.
oxytoca was isolated from 42 of 429 patients (9.8%) tested for C.
difficile cytotoxicity; only 10 isolates (23.8%) were cytotoxic [12].
It is likely that the low percentage of cytotoxin production among
the clinical isolates of K. oxytoca in both humans and animals is
due to the insensitivity of the current in vitro assays that do not
provide appropriate environmental cues necessary to induce
cytotoxin production in this bacterium. As demonstrated by our
results, cytotoxin production in K. oxytoca appears to be under
strict environmental regulation. Identifying environmental signals
that induce cytotoxin production in K. oxytoca may provide
additional insights into K. oxytoca pathogenesis and possible
therapeutic strategies.
The majority of mouse isolates of K. oxytoca in this study were
cultured from the feces or respiratory tract of sentinel rodents
during routine health screening. This suggests that the respiratory
and gastrointestinal tract may be the preferred site of colonization
by K. oxytoca in mice. However, the fact that a few isolates of K.
oxytoca were isolated from other tissues, including palpebral
conjunctiva, tumor, and, mammary gland, indicates that K.
oxytoca can also colonize other organs.
Antibiotic resistance patterns appear to vary considerably
among different strains of K. oxytoca. Strains of K. oxytoca are
resistant to amino-penicillins and carboxy-penicillins due to the
production of b-lactamases. Antimicrobial susceptibility testing
indicated that all of the K. oxytoca strains investigated were
resistant to ampicillin, suggesting these isolates of K.oxytoca are
able to synthesize B-lactamases. This is consistent with the
presence of beta-lactamases that encode a gene present in the
genome of K. oxytoca 09-7231. Resistance to amoxicillin/
clavuranate was also observed in select strains of K. oxytoca.
Interestingly, K. oxytoca isolates originating from non-human
primates showed resistance not only to ampicillin, cephalothin and
amoxicillin/clavuranate, but also to trimethoprim/sulfamethoxa-
zole, enrofloxacin, and gentamicin. The high percentage of
antibiotic-resistant strains of K. oxytoca isolated from nonhuman
primates may indicate the liberal use of antibiotics in primates,
particularly when the animals are in quarantine and placed on
prophylactic antibiotics prior to release for research purposes [30].
Genomic analysis of a cytotoxin-positive K. oxytoca isolated
from a clinically affected mouse revealed homologs of multiple
genes that promote pathogenicity in other pathogens. These
include type I, type IV, and type VI secretion systems. The type IV
secretion system promotes pathogenicity in H. pylori through
injection of cagA [50]. More recently, the type VI secretion system
has been demonstrated to promote bacterial competition, host cell
adhesion, and invasion in Escherichia coli, Campylobacter jejuni,
Salmonella spp [51,52]. In clinical isolates of K. pneumoniae,
cultured from a liver abscess in a human, genes involved in
allantoin metabolism were highly and uniquely upregulated, while
the non-clinical strain of K. pneumoniae lacked genes involved in
this metabolic pathway[53]. The mouse clinical isolate of K.
oxytoca investigated in this study also contains a large number of
genes involved in allantoin metabolism, including alls and allr,
which were found in the pathogenic strain of K. pneumoniae. This
suggests that, like K. pneumoniae [53], K. oxytoca may utilize
allantoin metabolism to initiate extraintestinal pathology, partic-
ularly in a pathological condition when high allantoin concentra-
tion in the tissues is present, while other nitrogen energy sources
are limited [53]. The K. oxytoca isolate also contains genes
involved in citrate fermentation, previously found in some clinical
isolates of K. pneumoniae, as well as genes encoding ecotin. The
presence of ecotin, a protease inhibitor present in Yersinia pestis,
E. coli and Pseudomonas aeruginosa, known to inhibit neutrophil
elastase, suggests that K. oxytoca may utilize this protein to
manipulate neutrophil function, thereby aiding the persistence of
the organism[54]. Indeed, K. oxytoca shows a remarkable ability to
persist in the gastrointestinal tract even after aggressive antibiotic
therapy with antibiotics that appear to be effective against other
resident bacteria [4]. In silico analysis also reveals three genes
present in the genome of K. oxytoca that show partial homology to
known toxins and toxin transporters previously identified in other
pathogenic bacteria, including PAXA, cholera toxin, and CFXB.
Further investigation is needed to determine the biological
relevance of these toxin homologs in K. oxytoca pathogenesis.
Initial description of a low-molecular-weight (,217 Da) cyto-
toxin, produced by cultured strains of K. oxytoca isolated from
humans with hemorrhagic diarrhea, was reported by Minami and
co-workers, although its structure was not characterized [22,23].
Mohr and Budzikiewicz had earlier identified a low molecular-
weight (333 Da) cytotoxic compound, produced by K. pneumoniae
serova oxytoca, as tilivalline [24]. Here we demonstrate that
cultured animal isolates of K. oxytoca also produce high levels of
tilivalline. The purified compound was tested in vitro for cytotoxic
properties and was found to induce cell abnormality and death in
HEp-2 cells confirming its cytotoxic property.
Previous studies to determine the molecular mechanisms of
toxin induced cell death in K. oxytoca suggest that the mechanism
is primarily through inhibition of DNA synthesis [22,23]. Our
whole transcriptomic profiling reveals that tilivalline induced
global perturbation of genes involved in numerous fundamental
cellular processes, including cell division, nitrogen metabolism,
RNA metabolic processing, DNA damage repair processes,
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apoptosis, and androgen signaling, as early as 6 hours after HEp-2
cells were exposed to the toxin when cell abnormalities are not yet
observed. Although the primary target of tilivalline may be in the
synthesis of DNA, our transcriptome data highlight the possibility
of simultaneous effects of tilivalline on multiple cellular processes
and pathways. Further investigations are required to determine the
exact mechanism of tilivalline-induced cell death.
In conclusion, this study provides evidence that - similar to K.
oxytoca strains in humans - animal isolates of K. oxytoca are
capable of producing cytotoxin in vitro. The roles that K. oxytoca
cytotoxin play in induction of genitourinary diseases or abscesses
in other tissues in mice and its pathogenic potential in other
animals remain to be defined.
Supporting Information
Figure S1 Cytotoxicity of supernatant on HEp-2 cells
subjected to A) 30K concentrate; B) 30 K filtrate; C) 3K
concentrate; D) 3K filtrate; E) heat-treated supernatant
of K. oxytoca, 09-7231-1; F) supernatant of K. oxytoca,
09-7231-1, without heat treatment. Note the low confluency
of B), C), D), and F) suggesting strong cytotoxic activity.
(TIF)
Figure S2 LC/MS total-ion chromatograms. A) soy broth
extract; B) soy broth extract from 9-hour toxic culture; C) soy
broth extract from 24-hour toxic culture; D) soy broth extract
from 16-hour culture of negative strain (non-toxic). Inset:
background-subtracted mass spectrum of the compound eluting
near 2.5 minutes.
(TIF)
Figure S3 MS/MS spectrum from m/z 334.156 (colli-
sion energy = 20 V), with suggested fragment struc-
tures.
(TIF)
Figure S4 1H NMR spectrum. Recorded on a Varian Inova-
500 instrument operating at 500.13 MHz using 5 mm O.D. thin-
walled precision NMR tubes (Wilmad). Chemical shifts are relative
to pyridine-d5 using Varian 5 mm PFG-probes at 22uC.
(TIF)
Figure S5 HPLC chromatogram with UV/vis detection
for the isolation oft tilivalline (24.3 min).
(TIF)
Figure S6 A volcano plot illustrated differentially regu-
lated genes.
(TIF)
Table S1 The most significantly perturbed genes (ad-
justed p-value ,0.05). In addition to the p-value from the
differential expression analysis, log-fold change and direction of
effect are shown.
(XLSX)
Table S2 The most significant Gene Ontology function-
al annotations. The most significant functional annotations
implicated by the differentially expressed genes include regulation
of RNA metabolic process (padjusted = 1.03610
235), regulation of
nitrogen compound metabolic process (padjusted = 1.46610
230),
negative regulation of apoptosis (padjusted = 1.2610
23), response to
DNA damage stimulus (padjusted = 1.75610
23), and cell cycle
(padjusted = 0.003).
(XLSX)
Table S3 Potential virulence genes found in K. oxytoca,
09-7231-1".
(DOCX)
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